This text is a result of machine translation.
The investment banking business was strictly supervised, and seven securities companies received fines
Biotech Astrabio Nets Nearly CNY 100 Mn in Series A financing Round
Astrabio, specializing in the Single Molecule Counting technology, will continue to promote the revolution of the next-generation immunoassay technology by further accelerating the R&D and clinical translation of new biomarkers with the fresh proceeds.
Updated 6 hours ago
The first batch of "Mao" concept achievements were released, with a year-on-year growth of more than 50%
Wantai biology: it is proposed to raise no more than 3.5 billion yuan for the phase II expansion project of nine price cervical cancer vaccine
Amazon: the policy is consistent all over the world, and the title is not for Chinese businesses
Biotech Firm ImmuneOnco Submitted Listing Application on the Main Board of HKEX
ImmuneOnco, focusing on developing new-generation tumor immunotherapeutic, will further accelerate the development of other promising drug candidates targeting checkpoints of innate and adaptive immunity.
Jun 28, 2022 10:58 PM
Zhang Kun's four funds decreased their positions in the second quarter by allocating Wuliangye to Guizhou Maotai
TC Medical's 1H 2020 Revenue Totals CNY 738 Mn, Down 12.87% YoY
A Closer Look at China’s Cloud Service Market, Guessing Who Will Succeed? [1/2]
Jun 27, 2022 05:09 PM
Exclusive Interview with Xu Qian, Managing Partner of Redhill Capital
Jun 27, 2022 12:24 PM